FocuSSced on the Target in Systemic Sclerosis-Interstitial Lung Disease Another Arrow in the Quiver?

被引：0
|
作者：
Matson, Scott M. [1 ]
Griffith, Melissa [2 ]
Lee, Joyce S. [2 ]
机构：
[1] Univ Kansas, Dept Med, Sch Med, Kansas City, KS 66160 USA
[2] Univ Colorado, Sch Med, Dept Med, Aurora, CO USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷 / 06期
关键词：
DOUBLE-BLIND; CYCLOPHOSPHAMIDE; PLACEBO;
D O I：
10.1164/rccm.202111-2587ED
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：608 / 610
页数：4
相关论文
共 50 条
  • [31] Treatment with Cyclophosphamide for Systemic Sclerosis-Interstitial Lung Disease Does Not Lead to a Sustained Improvement in Lung Function in Two Independent Cohorts
    Volkmann, Elizabeth R.
    Tashkin, Donald P.
    Sim, Myung
    Li, Ning
    Khanna, Dinesh
    Roth, Michael
    Clements, Philip J.
    Hoffmann-Vold, Anna-Maria
    Furst, Daniel E.
    Kim, Grace
    Goldin, Jonathan
    Elashoff, Robert
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [32] MYCOPHENOLATE MOPHETIL IN THE TREATMENT OF SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE (SSC-ILD) IN PATIENTS UNRESPONSIVE TO CYCLOPHOSPHAMIDE (CYC)
    Cuomo, G.
    Abignano, G.
    Iudici, M.
    Petrillo, A.
    Valentini, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S167 - S167
  • [33] The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database
    Lepri, Gemma
    Bruni, Cosimo
    Tofani, Lorenzo
    Moggi-Pignone, Alberto
    Orlandi, Martina
    Tomassetti, Sara
    Hughes, Michael
    Del Galdo, Francesco
    Irace, Rosaria
    Distler, Oliver
    Riccieri, Valeria
    Allanore, Yannick
    Gheorghiu, Ana Maria
    Siegert, Elise
    De Vries-Bouwstra, Jeska
    Hachulla, Eric
    Tikly, Mohammed
    Damjanov, Nemanja
    Spertini, Francois
    Mouthon, Luc
    Hoffmann-Vold, Anna-Maria
    Gabrielli, Armando
    Guiducci, Serena
    Matucci-Cerinic, Marco
    Furst, Daniel
    Bellando-Randone, Silvia
    DIAGNOSTICS, 2024, 14 (03)
  • [34] Reply: Quantitative Computed Tomography in Systemic Sclerosis-Interstitial Lung Disease: Are We Ready to Go beyond Standard Assessment?
    Saldana, Daniela Castillo
    Coxson, Harvey O.
    Ryerson, Christopher J.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (01) : 184 - 184
  • [35] Interstitial Lung Disease Associated with Systemic Sclerosis
    Mismetti, Valentine
    Si-Mohamed, Salim
    Cottin, Vincent
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 45 (03) : 342 - 364
  • [36] Interstitial lung disease in systemic sclerosis -: Diagnosis
    Hellmich, B
    Schnabel, A
    Bauer, T
    Dorfmüller, P
    Schatz, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (10) : 517 - 519
  • [37] Interstitial lung disease in systemic sclerosis: highlights
    Baverez, C.
    Sanges, S.
    REVUE DE MEDECINE INTERNE, 2021, 42 (10): : 10S3 - 10S8
  • [38] Interstitial lung disease in systemic sclerosis - Treatment
    Hellmich, B
    Schnabel, A
    Bauer, T
    Schatz, H
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (10) : 520 - 522
  • [39] Interstitial lung disease pathology in systemic sclerosis
    Konopka, Kristine E.
    Myers, Jeffrey L.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2021, 13
  • [40] Immunosuppression for interstitial lung disease in systemic sclerosis
    Cappelli, Susanna
    Guiducci, Serena
    Randone, Silvia Bellando
    Cerinic, Marco Matucci
    EUROPEAN RESPIRATORY REVIEW, 2013, 22 (129): : 236 - 243
12345